OCREVUS 300 mg/10mL
ocrelizumab · INJECTION · Genentech, Inc.
No Recall History
Plain English
OCREVUS is a injection containing ocrelizumab at 300 mg/10mL, taken intravenous. Manufactured by Genentech, Inc..
Key Facts
- Brand Name
- OCREVUS
- Generic Name
- ocrelizumab
- NDC Code (Product)
50242-150- Manufacturer
- Genentech, Inc.
- Strength
- 300 mg/10mL
- Dosage Form
- INJECTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761053
- Drug Class
- CD20-directed Cytolytic Antibody [EPC]
- Marketing Start
- 03/28/2017
Recall History
No Recall HistoryFrequently Asked Questions
What is OCREVUS used for?
OCREVUS contains ocrelizumab. It is a injection taken intravenous. Consult your doctor for specific uses.
Is OCREVUS a controlled substance?
OCREVUS is not classified as a controlled substance by the DEA.
What is the generic name for OCREVUS?
The generic name for OCREVUS is ocrelizumab. There are 1 other brand versions of ocrelizumab.
What is the NDC code for OCREVUS 300 mg/10mL?
The NDC (National Drug Code) for OCREVUS 300 mg/10mL is 50242-150, listed by Genentech, Inc..